You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on Human Metabolome Database.
Record Information |
---|
Version | 4.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2020-02-26 21:40:14 UTC |
---|
HMDB ID | HMDB0014731 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Ethosuximide |
---|
Description | Ethosuximide is only found in individuals that have used or taken this drug. It is an anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures. [PubChem]Binds to T-type voltage sensitive calcium channels. Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1G gives rise to T-type calcium currents. T-type calcium channels belong to the "low-voltage activated (LVA)" group and are strongly blocked by mibefradil. A particularity of this type of channels is an opening at quite negative potentials and a voltage-dependent inactivation. T-type channels serve pacemaking functions in both central neurons and cardiac nodal cells and support calcium signaling in secretory cells and vascular smooth muscle. They may also be involved in the modulation of firing patterns of neurons which is important for information processing as well as in cell growth processes. |
---|
Structure | |
---|
Synonyms | Value | Source |
---|
(+-)-2-Ethyl-2-methylsuccinimide | ChEBI | 2-Ethyl-2-methylsuccinimide | ChEBI | 2-Methyl-2-ethylsuccinimide | ChEBI | 3-Ethyl-3-methyl-2,5-pyrrolidinedione | ChEBI | 3-Ethyl-3-methylsuccinimide | ChEBI | 3-Methyl-3-ethylpyrrolidine-2,5-dione | ChEBI | 3-Methyl-3-ethylsuccinimide | ChEBI | Aethosuximide | ChEBI | alpha-Ethyl-alpha-methylsuccinimide | ChEBI | alpha-Methyl-alpha-ethylsuccinimide | ChEBI | Ethosuximidum | ChEBI | Etosuximida | ChEBI | gamma-Ethyl-gamma-methyl-succinimide | ChEBI | gamma-Methyl-gamma-ethyl-succinimide | ChEBI | Zarontin | Kegg | a-Ethyl-a-methylsuccinimide | Generator | Α-ethyl-α-methylsuccinimide | Generator | a-Methyl-a-ethylsuccinimide | Generator | Α-methyl-α-ethylsuccinimide | Generator | g-Ethyl-g-methyl-succinimide | Generator | Γ-ethyl-γ-methyl-succinimide | Generator | g-Methyl-g-ethyl-succinimide | Generator | Γ-methyl-γ-ethyl-succinimide | Generator | Ethosuccimide | HMDB | Ethosuccinimide | HMDB | Ethosuxide | HMDB | Desitin brand OF ethosuximide | HMDB | Ethylmethylsuccimide | HMDB | LAB brand OF ethosuximide | HMDB | Parke davis brand OF ethosuximide | HMDB | Pyknolepsinum | HMDB | Suxilep | HMDB | Emeside | HMDB | Faes brand OF ethosuximide | HMDB | Katwijk brand OF ethosuximide | HMDB | Pfizer brand OF ethosuximide | HMDB | Warner lambert brand OF ethosuximide | HMDB | Warner-lambert brand OF ethosuximide | HMDB | Fortbenton brand OF ethosuximide | HMDB | Jenapharm brand OF ethosuximide | HMDB | Suksilep | HMDB | Ethosuccimid | HMDB | Ethymal | HMDB | Etosuximida faes | HMDB | Faes, etosuximida | HMDB | Petnidan | HMDB | United drug brand OF ethosuximide | HMDB | Wernigerode brand OF ethosuximide | HMDB |
|
---|
Chemical Formula | C7H11NO2 |
---|
Average Molecular Weight | 141.1677 |
---|
Monoisotopic Molecular Weight | 141.078978601 |
---|
IUPAC Name | 3-ethyl-3-methylpyrrolidine-2,5-dione |
---|
Traditional Name | ethosuximide |
---|
CAS Registry Number | 77-67-8 |
---|
SMILES | CCC1(C)CC(=O)NC1=O |
---|
InChI Identifier | InChI=1S/C7H11NO2/c1-3-7(2)4-5(9)8-6(7)10/h3-4H2,1-2H3,(H,8,9,10) |
---|
InChI Key | HAPOVYFOVVWLRS-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as pyrrolidine-2-ones. These are pyrrolidines which bear a C=O group at position 2 of the pyrrolidine ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Pyrrolidines |
---|
Sub Class | Pyrrolidones |
---|
Direct Parent | Pyrrolidine-2-ones |
---|
Alternative Parents | |
---|
Substituents | - 2-pyrrolidone
- Carboxylic acid imide
- Dicarboximide
- Carboxylic acid imide, n-unsubstituted
- Lactam
- Carboxylic acid derivative
- Azacycle
- Carbonyl group
- Organooxygen compound
- Organonitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Aliphatic heteromonocyclic compound
|
---|
Molecular Framework | Aliphatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
|
Physiological effect | Health effect: |
---|
Disposition | Route of exposure: Biological location: |
---|
Role | Industrial application: |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | 64.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 101 g/L | Not Available | LogP | 0.1 | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
| Spectrum Type | Description | Splash Key | View |
---|
GC-MS | GC-MS Spectrum - EI-B (Non-derivatized) | splash10-08mi-9400000000-44583cdc88d3203a4e84 | Spectrum | GC-MS | GC-MS Spectrum - CI-B (Non-derivatized) | splash10-0006-1900000000-1c27ada66f7846f9d155 | Spectrum | GC-MS | GC-MS Spectrum - CI-B (Non-derivatized) | splash10-0006-2900000000-19e57defe9ded4ed42b4 | Spectrum | GC-MS | GC-MS Spectrum - EI-B (Non-derivatized) | splash10-08mi-9400000000-44583cdc88d3203a4e84 | Spectrum | GC-MS | GC-MS Spectrum - CI-B (Non-derivatized) | splash10-0006-1900000000-1c27ada66f7846f9d155 | Spectrum | GC-MS | GC-MS Spectrum - CI-B (Non-derivatized) | splash10-0006-2900000000-19e57defe9ded4ed42b4 | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-056r-9300000000-85b98f89652d40beec08 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0006-0900000000-86a82d1f0e8a43f11ab5 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-006x-3900000000-e43cf4042ca22cb5d6a8 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0q29-9000000000-0593295be197f643992c | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0006-1900000000-7b6a825d9781021fd166 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0006-3900000000-a161e0f30f683c657129 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0f6x-9000000000-25a91a77a1c19188305e | Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-08mi-9300000000-3d87944377ee1f85803d | Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00593 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00593 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Predicted Concentrations |
---|
| |
Blood | 0.000 uM | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities | Blood | 0.000 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities |
|
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB00593 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 3175 |
---|
KEGG Compound ID | C07505 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Ethosuximide |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 3291 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 4887 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Kostyuk PG, Molokanova EA, Pronchuk NF, Savchenko AN, Verkhratsky AN: Different action of ethosuximide on low- and high-threshold calcium currents in rat sensory neurons. Neuroscience. 1992 Dec;51(4):755-8. [PubMed:1336826 ]
- Coulter DA, Huguenard JR, Prince DA: Differential effects of petit mal anticonvulsants and convulsants on thalamic neurones: calcium current reduction. Br J Pharmacol. 1990 Aug;100(4):800-6. [PubMed:2169941 ]
- Coulter DA, Huguenard JR, Prince DA: Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons. Ann Neurol. 1989 Jun;25(6):582-93. [PubMed:2545161 ]
- Coulter DA, Huguenard JR, Prince DA: Specific petit mal anticonvulsants reduce calcium currents in thalamic neurons. Neurosci Lett. 1989 Mar 13;98(1):74-8. [PubMed:2710401 ]
- Patsalos PN: Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies. Epilepsia. 2005;46 Suppl 9:140-8. [PubMed:16302888 ]
|
---|